# MANAGE Automated Glucose Monitoring

> **NCT02211300** · NA · UNKNOWN · sponsor: **OptiScan Biomedical Corporation** · enrollment: 230 (estimated)

## Conditions studied

- ICU/CCU Patients Requiring Blood Glucose Monitoring

## Interventions

- **DEVICE:** The OptiScanner
- **DEVICE:** YSI 2300 STAT Plus™

## Key facts

- **NCT ID:** NCT02211300
- **Lead sponsor:** OptiScan Biomedical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2015-09
- **Final completion:** 2015-12
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2015-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02211300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02211300, "MANAGE Automated Glucose Monitoring". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02211300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*